Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Ferdinandos Skoulidis; Haniel A. Araújo; Minh Truong; Yu Qian; Xin Sun; Ana Galán‐Cobo; John T. Le; Meagan Montesion; Rachael Palmer; Nadine S. Jahchan; Joseph Juan; Chengyin Min; Yi Yu; Xuewen Pan; Kathryn C. Arbour; Natalie I. Vokes; Stephanie Schmidt; David Molkentine; Dwight H. Owen; Regan Memmott; Pradnya D. Patil; Melina E. Marmarelis; Mark M. Awad; Joseph C. Murray; Jessica A. Hellyer; Justin F. Gainor; Anastasios Dimou; Christine M. Bestvina; Catherine A. Shu; Jonathan W. Riess; Collin M. Blakely; Chad V. Pecot; Laura Mezquita; Fabrizio Tabbò; Matthias Scheffler; Subba R. Digumarthy; Meghan J. Mooradian; Adrian G. Sacher; Sally C. M. Lau; Andreas Saltos; Julia Rotow; Rocio Perez Johnson; Corinne Liu; Tyler F. Stewart; Sarah B. Goldberg; Jonathan Killam; Zenta Walther; Kurt A. Schalper; Kurtis D. Davies; Mark G. Woodcock; Valsamo Anagnostou; Kristen A. Marrone; Patrick M. Forde; Biagio Ricciuti; Deepti Venkatraman; Eliezer M. Van Allen; Amy L. Cummings; Jonathan W. Goldman; Hiram Shaish; Melanie Wain Kier; Sharyn I. Katz; Charu C. Aggarwal; Ying Ni; Joseph T. Azok; Jeremy Segal; Lauren L. Ritterhouse; Joel W. Neal; Ludovic Lacroix; Yasir Y. Elamin; Marcelo V. Negrão; Xiuning Le; Vincent K. Lam; Whitney E. Lewis; Haley N. Kemp; Brett Carter; Jack A. Roth; Stephen G. Swisher; Richard Lee; Teng Zhou; Alissa Poteete; Yifan Kong; Tomohiro Takehara; Alvaro Guimaraes Paula; Edwin R. Parra; Carmen Behrens; Ignacio I. Wistuba; Jianjun Zhang; George R. Blumenschein; Carl M. Gay; Lauren A. Byers; Don L. Gibbons; Anne S. Tsao; J. Jack Lee; Trever G. Bivona; D. Ross Camidge; J.E. Gray; Natasha B. Leighl; Benjamin Levy; Julie R. Brahmer; Marina Chiara Garassino; David R. Gandara; Edward B. Garon; Naiyer A. Rizvi; Giorgio V. Scagliotti; Jürgen Wolf; David Planchard; Benjamin Besse; Roy S. Herbst; Heather A. Wakelee; Nathan A. Pennell; Alice T. Shaw; Pasi A. Jänne; David P. Carbone; Matthew D. Hellmann; Charles M. Rudin; Lee A. Albacker; Helen Mann; Zhu Zhou; Zhongwu Lai; Ross Stewart; Solange Peters; Melissa L. Johnson; Kwok‐Kin Wong; Alan Huang; Monte M. Winslow; Michael Rosen; Ian P. Winters; Vassiliki A. Papadimitrakopoulou; Tina Cascone; Philip J. Jewsbury; John V. Heymach

doi:10.1038/s41586-025-08767-9

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Ferdinandos Skoulidis(The University of Texas MD Anderson Cancer Center), Haniel A. Araújo(The University of Texas MD Anderson Cancer Center), Minh Truong(The University of Texas MD Anderson Cancer Center), Yu Qian(The University of Texas MD Anderson Cancer Center), Xin Sun(The University of Texas MD Anderson Cancer Center), Ana Galán‐Cobo(The University of Texas MD Anderson Cancer Center), John T. Le(The University of Texas MD Anderson Cancer Center), Meagan Montesion(Foundation Medicine (United States)), Rachael Palmer, Nadine S. Jahchan, Joseph Juan(NRG Oncology), Chengyin Min(Tango Therapeutics (United States)), Yi Yu(Tango Therapeutics (United States)), Xuewen Pan(Tango Therapeutics (United States)), Kathryn C. Arbour(Memorial Sloan Kettering Cancer Center), Natalie I. Vokes(The University of Texas MD Anderson Cancer Center), Stephanie Schmidt(The University of Texas MD Anderson Cancer Center), David Molkentine(The University of Texas MD Anderson Cancer Center), Dwight H. Owen(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Regan Memmott(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Pradnya D. Patil(Cleveland Clinic), Melina E. Marmarelis(University of Pennsylvania), Mark M. Awad(Dana-Farber Cancer Institute), Joseph C. Murray(Johns Hopkins University), Jessica A. Hellyer(Stanford University), Justin F. Gainor(Massachusetts General Hospital), Anastasios Dimou(Mayo Clinic in Arizona), Christine M. Bestvina(University of Chicago), Catherine A. Shu(Columbia University), Jonathan W. Riess(UC Davis Comprehensive Cancer Center), Collin M. Blakely(University of California, San Francisco), Chad V. Pecot(UNC Lineberger Comprehensive Cancer Center), Laura Mezquita(Hospital Clínic de Barcelona), Fabrizio Tabbò(Ospedale San Pietro Fatebenefratelli), Matthias Scheffler(University Hospital Cologne), Subba R. Digumarthy(Massachusetts General Hospital), Meghan J. Mooradian(Massachusetts General Hospital), Adrian G. Sacher(Princess Margaret Cancer Centre), Sally C. M. Lau(NYU Langone Health), Andreas Saltos(Moffitt Cancer Center), Julia Rotow(Dana-Farber Cancer Institute), Rocio Perez Johnson(Memorial Sloan Kettering Cancer Center), Corinne Liu(Memorial Sloan Kettering Cancer Center), Tyler F. Stewart(University of California San Diego), Sarah B. Goldberg(Yale University), Jonathan Killam(North Shore University Hospital), Zenta Walther(Yale University), Kurt A. Schalper(Yale University), Kurtis D. Davies(University of Colorado Anschutz Medical Campus), Mark G. Woodcock(UNC Lineberger Comprehensive Cancer Center), Valsamo Anagnostou(Johns Hopkins University), Kristen A. Marrone(Johns Hopkins University), Patrick M. Forde(Johns Hopkins University), Biagio Ricciuti(Dana-Farber Cancer Institute), Deepti Venkatraman(Dana-Farber Cancer Institute), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Amy L. Cummings(University of California, Los Angeles), Jonathan W. Goldman(University of California, Los Angeles), Hiram Shaish(Columbia University), Melanie Wain Kier(Icahn School of Medicine at Mount Sinai), Sharyn I. Katz(University of Pennsylvania), Charu C. Aggarwal(University of Pennsylvania), Ying Ni(Cleveland Clinic), Joseph T. Azok(Cleveland Clinic), Jeremy Segal(University of Chicago), Lauren L. Ritterhouse(Foundation Medicine (United States)), Joel W. Neal(Stanford University), Ludovic Lacroix(Institut Gustave Roussy), Yasir Y. Elamin(The University of Texas MD Anderson Cancer Center), Marcelo V. Negrão(The University of Texas MD Anderson Cancer Center), Xiuning Le(The University of Texas MD Anderson Cancer Center), Vincent K. Lam(Johns Hopkins University), Whitney E. Lewis(The University of Texas MD Anderson Cancer Center), Haley N. Kemp(The University of Texas MD Anderson Cancer Center), Brett Carter(The University of Texas MD Anderson Cancer Center), Jack A. Roth(The University of Texas MD Anderson Cancer Center), Stephen G. Swisher(The University of Texas MD Anderson Cancer Center), Richard Lee(The University of Texas MD Anderson Cancer Center), Teng Zhou(The University of Texas MD Anderson Cancer Center), Alissa Poteete(The University of Texas MD Anderson Cancer Center), Yifan Kong(The University of Texas MD Anderson Cancer Center), Tomohiro Takehara(The University of Texas MD Anderson Cancer Center), Alvaro Guimaraes Paula(The University of Texas MD Anderson Cancer Center), Edwin R. Parra(The University of Texas MD Anderson Cancer Center), Carmen Behrens(The University of Texas MD Anderson Cancer Center), Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), Jianjun Zhang(The University of Texas MD Anderson Cancer Center), George R. Blumenschein(The University of Texas MD Anderson Cancer Center), Carl M. Gay(The University of Texas MD Anderson Cancer Center), Lauren A. Byers(The University of Texas MD Anderson Cancer Center), Don L. Gibbons(The University of Texas MD Anderson Cancer Center), Anne S. Tsao(The University of Texas MD Anderson Cancer Center), J. Jack Lee(The University of Texas MD Anderson Cancer Center), Trever G. Bivona(University of California, San Francisco), D. Ross Camidge(University of Colorado Cancer Center), J.E. Gray(Moffitt Cancer Center), Natasha B. Leighl(Princess Margaret Cancer Centre), Benjamin Levy(Johns Hopkins University), Julie R. Brahmer(Johns Hopkins University), Marina Chiara Garassino(University of Chicago), David R. Gandara(UC Davis Comprehensive Cancer Center), Edward B. Garon(University of California, Los Angeles), Naiyer A. Rizvi(Menlo School), Giorgio V. Scagliotti(University of Turin), Jürgen Wolf(University Hospital Cologne), David Planchard(Institut Gustave Roussy), Benjamin Besse(Institut Gustave Roussy), Roy S. Herbst(Yale University), Heather A. Wakelee(Stanford University), Nathan A. Pennell(Cleveland Clinic), Alice T. Shaw(Novartis (United States)), Pasi A. Jänne(Dana-Farber Cancer Institute), David P. Carbone(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Matthew D. Hellmann(AstraZeneca (United States)), Charles M. Rudin(Memorial Sloan Kettering Cancer Center), Lee A. Albacker(Foundation Medicine (United States)), Helen Mann(AstraZeneca (United Kingdom)), Zhu Zhou(AstraZeneca (United Kingdom)), Zhongwu Lai(AstraZeneca (United Kingdom)), Ross Stewart(AstraZeneca (United Kingdom)), Solange Peters(University Hospital of Lausanne), Melissa L. Johnson(Sarah Cannon), Kwok‐Kin Wong(NYU Langone Health), Alan Huang(Tango Therapeutics (United States)), Monte M. Winslow(NRG Oncology), Michael Rosen(NRG Oncology), Ian P. Winters(NRG Oncology), Vassiliki A. Papadimitrakopoulou(Pfizer (United States)), Tina Cascone(The University of Texas MD Anderson Cancer Center), Philip J. Jewsbury(AstraZeneca (United Kingdom)), John V. Heymach(The University of Texas MD Anderson Cancer Center)

Nature

February 27, 2025

10.1038/s41586-025-08767-9

Cited by 1Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis